SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-255459
Filing Date
2013-06-12
Accepted
2013-06-12 08:31:23
Documents
4
Period of Report
2013-06-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d552936d8k.htm 8-K 15569
2 EX-99.1 d552936dex991.htm EX-99.1 12220
3 GRAPHIC g552936im1.jpg GRAPHIC 11799
4 GRAPHIC g552936im2.jpg GRAPHIC 31614
  Complete submission text file 0001193125-13-255459.txt   89088
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 13907929
SIC: 2834 Pharmaceutical Preparations